Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Oncology
CancerLinQ Moves to Its Patient Data-Gathering Clinical Phase
By
Rosemary Frei, MSc
Oncology
May 2015, Vol 6, No 4
The American Society of Clinical Oncology (ASCO) and a German company called SAP are launching the clinical phase of ASCO’s big-data initiative—CancerLinQ. This clinical phase is focused on gathering and analyzing data from the 97% of US patients with cancer who do not participate in clinical trials.
Read Article
Harnessing CMS’s Meaningful Use Criteria to Transform Cancer Care with EMRs
By
Rosemary Frei, MSc
Cancer Care
,
Oncology
,
Personalized Medicine
April 2014, Vol 5, No 3
Washington, DC—A new framework for transforming cancer care by harnessing the meaningful use criteria of the Centers for Medicare & Medicaid Services (CMS) was proposed by a team of researchers at the 2013 American Medical Informatics Association meeting.
Read Article
High Rate of Overridden Drug Contraindication Alerts for Patients with Cancer
By
Rosemary Frei, MSc
Oncology
April 2014, Vol 5, No 3
Washington, DC—Patients with cancer are often prescribed medications for the treatment of comorbid conditions, and some of those medications may have harmful drug interactions with the therapies used to treat their cancer. Computerized alert systems are now being used to inform providers or support personnel on such contraindications.
Read Article
eviti: Decision Support at the Point of Care for Oncologists
By
Arlene A. Forastiere, MD
Oncology
May 2012, Vol 3, No 3
An independent health information technology company, eviti, Inc, provides a suite of web-based decision-support services that connects and delivers value to all parties in the care process—patients receive quality care, physicians are assured payment, insurers pay for quality care only, and pharmacy benefit managers (PBMs) or specialty pharmacy improve adherence.
Read Article
The Pace of Change in Oncology Management Greater than the Sum of Its Parts
By
Lee Goldberg
Oncology
December 2011, Vol 2, No 7
Innovative medications target the molecular structure of cancer cells with increasing precision, resulting in reduced adverse effects. Novel therapies enlist the patients’ own immune systems to defeat cancer. At the same time, as personalized medicine comes of age, improved diagnostic tests match the right patients to these new treatments.
Read Article
Noise-Canceling Information
By
Ron Ribitzky, MD
Oncology
October 2011, Vol 2, No 6
New discoveries in diagnosis, treatment, and prevention of cancer abound, but what is just “noise”? What is in oncology that is interesting, intriguing, inspiring, yet still just “noise,” because the path to action “here and now” is missing, or not obvious?
Read Article
The First NCQA-Recognized Medical Home in Oncology
By
John D. Sprandio, MD, FACP
Oncology
October 2011, Vol 2, No 6
The patient-centered medical home (PCMH) model of care has proved successful in overcoming some of the fragmentation of primary care. Dr Sprandio and his colleagues have now demonstrated the value of applying the principles of the medical home to cancer care, with particular implications for oncologists and for payers and unique reimbursement dilemmas.
Read Article
Dose-Monitoring, Split-Fill Programs Reduce Oral Chemotherapy Waste, Save Costs
By
Caroline Helwick
Oncology
August 2011, Vol 2, No 5
Dose-monitoring programs for oral chemotherapy drugs can reduce wastage and reduce the risk of serious adverse effects associated with these drugs.
Read Article
Northwestern University Comprehensive Cancer Center
Oncology
August 2011, Vol 2, No 5
Interview with Al B. Benson III, MD, FACP,
Professor of Medicine and Associate Director for Clinical Investigations, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
Read Article
The Impact of Therapy Type on Clinical Fragmentation in Oncology Care
By
Wayne Kuznar
Oncology
July 2011, Vol 2, No 4
Fragmentation in oncology care significantly influences physicians’, payers’, and patients’ understanding of how cancer therapies lead to improved quality of care.
Read Article
Page 1 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma